Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc A Simon

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
ESC Heart Failure|June 27, 2025
Heart transplantation outcomes with donation after circulatory death in patients with left ventricular assist deviceAris Karatasakis, Edwin Grajeda Silvestri, Gatha G Nair, et al.
Pulmonary Circulation|May 4, 2022
An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertensionMarc A Simon, Kate Hanrott, David C Budd, et al.
Transplantation|April 30, 2020
The Preimplantation Psychosocial Evaluation and Prediction of Clinical Outcomes During Mechanical Circulatory Support: What Information Is Most Prognostic?Mary Amanda Dew, Jennifer C Hollenberger, Laura L Obregon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 30, 2024
Plasma Proteomics Identifies B2M as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection FractionJia-Rong Jheng, Jacqueline T DesJardin, Yi-Yun Chen, et al.
JACC. Heart Failure|April 11, 2021
Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP TrialDaniel Burkhoff, Barry A Borlaug, Sanjiv J Shah, et al.
Circulation|May 28, 2024
Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection FractionJia-Rong Jheng, Yang Bai, Kentaro Noda, et al.
Pulmonary Circulation|March 12, 2019
Distinct plasma gradients of microRNA-204 in the pulmonary circulation of patients suffering from WHO Groups I and II pulmonary hypertensionLeonard E Estephan, Michael V Genuardi, Chad M Kosanovich, et al.
JAMA Cardiology|August 3, 2017
Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction: Association With Baseline Disease Severity and Subsequent OutcomeErik B Schelbert, Yaron Fridman, Timothy C Wong, et al.
Heart (British Cardiac Society)|February 14, 2023
Pulmonary artery compliance in different forms of pulmonary hypertensionAmber McCormick, Amita Krishnan, David Badesch, et al.
Pulmonary Circulation|July 10, 2014
First successful lung transplantation for sickle cell disease with severe pulmonary arterial hypertension and pulmonary veno-occlusive diseaseM Patricia George, Enrico M Novelli, Norihisa Shigemura, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
ESC Heart Failure|June 27, 2025
Heart transplantation outcomes with donation after circulatory death in patients with left ventricular assist deviceAris Karatasakis, Edwin Grajeda Silvestri, Gatha G Nair, et al.
Pulmonary Circulation|May 4, 2022
An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertensionMarc A Simon, Kate Hanrott, David C Budd, et al.
Transplantation|April 30, 2020
The Preimplantation Psychosocial Evaluation and Prediction of Clinical Outcomes During Mechanical Circulatory Support: What Information Is Most Prognostic?Mary Amanda Dew, Jennifer C Hollenberger, Laura L Obregon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 30, 2024
Plasma Proteomics Identifies B2M as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection FractionJia-Rong Jheng, Jacqueline T DesJardin, Yi-Yun Chen, et al.
JACC. Heart Failure|April 11, 2021
Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP TrialDaniel Burkhoff, Barry A Borlaug, Sanjiv J Shah, et al.
Circulation|May 28, 2024
Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection FractionJia-Rong Jheng, Yang Bai, Kentaro Noda, et al.
Pulmonary Circulation|March 12, 2019
Distinct plasma gradients of microRNA-204 in the pulmonary circulation of patients suffering from WHO Groups I and II pulmonary hypertensionLeonard E Estephan, Michael V Genuardi, Chad M Kosanovich, et al.
JAMA Cardiology|August 3, 2017
Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction: Association With Baseline Disease Severity and Subsequent OutcomeErik B Schelbert, Yaron Fridman, Timothy C Wong, et al.
Heart (British Cardiac Society)|February 14, 2023
Pulmonary artery compliance in different forms of pulmonary hypertensionAmber McCormick, Amita Krishnan, David Badesch, et al.
Pulmonary Circulation|July 10, 2014
First successful lung transplantation for sickle cell disease with severe pulmonary arterial hypertension and pulmonary veno-occlusive diseaseM Patricia George, Enrico M Novelli, Norihisa Shigemura, et al.
Pageof 13